Investors Watch List : B.O.S. Better Online Solutions (NASDAQ:BOSC), Rite Aid (NYSE:RAD), Hologic (NASDAQ:HOLX), PharmAthene, Inc. (NYSEMKT:PIP), Digital Ally (NASDAQ:DGLY)

B.O.S. Better Online Solutions Ltd. (“BOS”) (NASDAQ:BOSC), a leading Israeli provider of RFID and supply chain solutions to global enterprises, announced today that it has scheduled the release of its financial results for the second quarter of year 2014 to Thursday, August 21 2014. B.O.S. Better Online Solutions Ltd. (NASDAQ:BOSC) belongs to Technology sector. Its net profit margin is 0.40% and weekly performance is -0.17%. On last trading day company shares ended up $3.48. B.O.S. Better Online Solutions Ltd. (NASDAQ:BOSC) distance from 50-day simple moving average (SMA50) is -10.57%.

Drugstore retailers such as Rite Aid Corporation (NYSE:RAD) are having a tough time because of increasing costs of drugs and lower third party reimbursements. These issues are taking a toll on the top line as well as the bottom line. Rite Aid Corporation (NYSE:RAD) shares moved down -8.70% in last trading session and ended the day at $5.98. RAD Gross Margin is 28.40% and its return on assets is 2.40%. Rite Aid Corporation (NYSE:RAD) quarterly performance is -22.44%.

Hologic, Inc. (NASDAQ:HOLX), a medical device and diagnostics manufacturer, saw an unprecedented increase in investors’ interest, after the billionaire activist investor, Carl Icahn, purchased a 12.5% stake in the company last November. On 06 August, Hologic Inc. (NASDAQ:HOLX) shares moved down -0.27% and was closed at $25.59. HOLX EPS growth in last 5 year was -20.90%. Hologic Inc. (NASDAQ:HOLX) year to date (YTD) performance is 14.50%. PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial and operational results for the second quarter of 2014. For the three months ended June 30, 2014, PharmAthene recognized revenue of approximately $3.7 million, compared to approximately $4.3 million for the corresponding period in 2013. Revenue was derived primarily from contracts with the U.S. government for the development of the Company’s biodefense product candidates. PharmAthene, Inc. (NYSEMKT:PIP) ended the last trading day at $1.26. Company weekly volatility is calculated as 3.16%and price to cash ratio as 7.23. PharmAthene, Inc. (NYSEMKT:PIP) showed a weekly performance of -1.56%.

On March 21, 2014, Digital Ally, Inc. (NASDAQ:DGLY) entered into definitive agreements relating to a private placement (the “Private Placement”) of a $2.0 million principal amount Senior Secured Convertible Note due on March 24, 2016 (the “Note”). The closing of the Private Placement occurred on March 24, 2014. The Note is convertible at any time at the option of the holder into shares of the Company’s common stock at $8.55 per share (the “Conversion Price”). On July 10, 2014 the Company and the holder of the Note entered into a Voluntary Adjustment and Consent Agreement under which they agreed to reduce the Conversion Price of the Note to $6.25 per share during the period from July 11 to July 14, 2014. During the foregoing period the holder converted $1,777,777.76 principal amount and $2,963.04 accrued interest on the Note into 284,928 shares of common stock of the Company. On July 15, 2014 the Conversion Price returned to $8.55 per share. Digital Ally Inc. (NASDAQ:DGLY) shares moved down -5.26% in last trading session and ended the day on $3.60. DGLY Gross Margin is 56.50% and its return on assets is -25.40%. Digital Ally Inc. (NASDAQ:DGLY) quarterly performance is -24.84%.